Health CareHealth Care Equipment & Services
  • Price (USD)134.45
  • Today's Change1.51 / 1.14%
  • Shares traded1.30m
  • 1 Year change22.90%
  • Beta0.8367
Data delayed at least 15 minutes, as of Apr 24 2017 21:02 BST.
More ▼

Events & Activity

  • SYK:NYQ price reached a new 52-week high of 134.02 at 10:30 BST
  • SYK:NYQ price moved over +1.11% to 134.42
  • SYK:NYQ trading volume exceeds daily average by +26.01%
  • On date 08 Feb 2017, SYK:NYQ announced a new dividend of amount 0.425 payable on date 08 Feb 2017

Key statistics

On Monday, Stryker Corp (SYK:NYQ) closed at 134.45, -0.25% below its 52-week high of 134.79, set on Apr 24, 2017.
52-week range
106.48Nov 14 2016134.79Apr 24 2017
Markit short selling activity
Previous close134.45
Average volume981.43k
Shares outstanding373.07m
Free float317.85m
P/E (TTM)30.90
Market cap50.16bn USD
Annual div (ADY)1.70 USD
Annual div yield (ADY)1.28%
Div ex-dateMar 29 2017
Div pay-dateApr 28 2017
Data delayed at least 15 minutes, as of Apr 24 2017 21:02 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.